News

Ajinomoto Bio-Pharma Services signs manufacturing agreement with Humanigen for Lenzilumab

Lenzilumab is currently being studied in a Phase III clinical trial in adult, hospitalized patients with COVID-19.

Read More

May 28, 2020

By : Team ABLE

DST-SERB supports study for identification of structure-based potential antivirals against COVID 19

In this study, a computer-based high throughput virtual screening approach will be used to identify antiviral molecules from different compound libraries

Read More

May 28, 2020

By : Team ABLE

Biocon Biologics gets DCGI nod for blood purification device to treat COVID-19 patients

India’s drug regulator, DCGI has approved CytoSorb, an extracorporeal blood purification (EBP) device, developed by Biocon Biologics,to reduce pro-inflammatory cytokines levels in confirmed COVID patients with confirmed or imminent respiratory failure.

Read More

May 27, 2020

By : Team ABLE

CSIR-IIIM & Reliance Industries to develop RT-LAMP based test for Coronavirus

RT-LAMP a rapid, accurate and cost-effective test can be done with indigenous components and set up with minimal expertise and instrumentation

Read More

May 27, 2020

By : Team ABLE

Boehringer Ingelheim, Eli Lilly to collaborate with Duke Institute for heart disease research

The collaboration will investigate whether empagliflozin can improve outcomes and prevent heart failure in adults with and without diabetes

Read More

May 27, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights